Systemic BCG-Osis as a Rare Side Effect of Intravesical BCG Treatment for Superficial Bladder Cancer

Intravesical Bacilli Calmette-Guérin (BCG) immunotherapy is a commonly used treatment for superficial bladder cancer. Although the treatment is well tolerated in 95% of cases, life-threatening side effects including BCG sepsis can occur. This report describes the case of an 82-year-old man with a ba...

Descripción completa

Detalles Bibliográficos
Autores principales: Lukacs, S., Tschobotko, B., Szabo, N. A., Symes, Andrew
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Hindawi Publishing Corporation 2013
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703374/
https://www.ncbi.nlm.nih.gov/pubmed/23844314
http://dx.doi.org/10.1155/2013/821526

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3703374/
https://www.ncbi.nlm.nih.gov/pubmed/23844314
http://dx.doi.org/10.1155/2013/821526

Ejemplares similares